Genetic Signatures Ltd is a molecular diagnostics company specializing in syndromic testing for infectious diseases. The company develops and manufactures multiplex real-time PCR assays under the EasyScreen brand, enabling the detection of over 100 clinically relevant pathogens. Genetic Signatures' innovative 3base technology improves PCR efficiency and reduces genetic complexity, allowing for more accurate and efficient detection of pathogens. The company's products and services support hospitals, diagnostic laboratories, and research institutions in streamlining workflows, enhancing patient management, and improving disease surveillance. With a focus on configurable testing solutions, Genetic Signatures addresses the evolving needs of the healthcare and life sciences industries.

Genetic Signatures is an established, global molecular diagnostics company providing configurable syndromic testing for a broad range of infectious diseases – Syndromic Testing, Your Way. The Company manufactures multiplex real-time PCR assays under the EasyScreen™ brand to support detection of over 100 clinically relevant pathogens. EasyScreenTM detection kits use patented, innovative 3base® technology which chemically converts the naturally occurring 4-base genome to one of 3 bases. This improves PCR efficiency and reduces the genetic complexity of detecting pathogens. This is particularly beneficial for detecting pathogen subtypes and providing increased resistance to mutations or variants, as observed with SARS-CoV-2.

Genetic Signatures’ EasyScreenTM detection kits are offered in conjunction with a suite of automated systems which enable an end-to-end streamlined workflow. Hospitals and diagnostic laboratories value the ability detect a large number of pathogens in a single sample, whist preserving throughput, providing timely and accurate diagnosis to improve patient management, and disease surveillance. Products are used for IVD use and research purposes.

ISO13485

Gastrointestinal Infections
Respiratory
Sexual Health
Anti-Microbial Resistance
Meningitis
Tropical Disease

2001